SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-317782
Filing Date
2021-11-03
Accepted
2021-11-03 08:51:05
Documents
14
Period of Report
2021-11-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d193784d8k.htm   iXBRL 8-K 24951
2 EX-99.1 d193784dex991.htm EX-99.1 7341
6 GRAPHIC g193784g1102235155079.jpg GRAPHIC 2940
  Complete submission text file 0001193125-21-317782.txt   165135

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nerv-20211103.xsd EX-101.SCH 2915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20211103_lab.xml EX-101.LAB 18907
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20211103_pre.xml EX-101.PRE 11878
7 EXTRACTED XBRL INSTANCE DOCUMENT d193784d8k_htm.xml XML 3474
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36517 | Film No.: 211373861
SIC: 2834 Pharmaceutical Preparations